Oftared Logo Banner enfermedades oculares
slide

Publicaciones volver

Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration.

Tipo: Artículo
Autores: Calvo-González C, Reche-Frutos J, Donate-López J, García-Feijoó J, Leila M, Fernández-Pérez C, Garcia-Sánchez J.
Títuto Revista: British Journal of Ophthalmology
Referencia:
Centro: 06 - UCM - IIORC
Br J Ophthalmol. 2008 Jan;92(1):74-5.

Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration.

Source

Hospital Universitario Clínico San Carlos, Madrid, Spain. calvo_glez@yahoo.es

Abstract

AIMS:

This prospective, open label, non-comparative, observational case series evaluates 6-month results of Pegaptanib Sodium (Macugen) and Photodynamic Therapy (PDT) in predominantly classic juxtafoveal choroidal neovascularisation (CNV) in age-related macular degeneration (AMD) in seven eyes of seven patients.

RESULTS:

Best corrected visual acuity (BCVA) diminished with a mean of five letters. Initial area of CNV increased significantly from 1.4 mm2 to 2.7 mm2. There was a significant increase in the greatest linear dimension (GLD) from 1280.3 microm to 2065.7 microm at the 24-week follow-up.

CONCLUSION:

Predominantly classic juxtafoveal CNVs are highly aggressive lesions that demonstrate poor response despite combined therapy using PDT and Macugen.

PMID:
18156376
[PubMed - indexed for MEDLINE]